Matches in Wikidata for { <http://www.wikidata.org/entity/Q37096469> ?p ?o ?g. }
- Q37096469 description "2013 ആഗസ്റ്റ് 14 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q37096469 description "article científic" @default.
- Q37096469 description "article scientifique" @default.
- Q37096469 description "articolo scientifico" @default.
- Q37096469 description "artigo científico" @default.
- Q37096469 description "artículu científicu espublizáu n'agostu de 2013" @default.
- Q37096469 description "bilimsel makale" @default.
- Q37096469 description "scientific article published on 14 August 2013" @default.
- Q37096469 description "vedecký článok" @default.
- Q37096469 description "vetenskaplig artikel" @default.
- Q37096469 description "videnskabelig artikel" @default.
- Q37096469 description "vědecký článek" @default.
- Q37096469 description "wetenschappelijk artikel" @default.
- Q37096469 description "wissenschaftlicher Artikel" @default.
- Q37096469 description "наукова стаття, опублікована в серпні 2013" @default.
- Q37096469 description "научни чланак" @default.
- Q37096469 description "مقالة علمية نشرت في 14 أغسطس 2013" @default.
- Q37096469 name "Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma" @default.
- Q37096469 name "Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma." @default.
- Q37096469 type Item @default.
- Q37096469 label "Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma" @default.
- Q37096469 label "Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma." @default.
- Q37096469 prefLabel "Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma" @default.
- Q37096469 prefLabel "Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma." @default.
- Q37096469 P1433 Q37096469-5408221F-D2D6-4CCD-83DC-E4CD2712ADC5 @default.
- Q37096469 P1476 Q37096469-0E22F46B-7160-465F-AB4D-2E5846B0CFBD @default.
- Q37096469 P2093 Q37096469-60220C77-2ABA-4631-A924-85FD9E29242B @default.
- Q37096469 P2093 Q37096469-800A87A5-C036-4B0D-8F8D-274F2FA5C5D6 @default.
- Q37096469 P2093 Q37096469-A71703F6-4207-4CD4-978E-43B5DCB399BE @default.
- Q37096469 P2093 Q37096469-D8B0402A-AF2A-4465-8159-1078D7F33C49 @default.
- Q37096469 P2093 Q37096469-E5C4D4F2-CC5D-46D0-A024-F3F32DF789D2 @default.
- Q37096469 P2093 Q37096469-E69914BD-C9EB-496D-A2F0-44EE0A1BFE5B @default.
- Q37096469 P2860 Q37096469-01455D56-EB76-4223-89C6-A300C94DD1C9 @default.
- Q37096469 P2860 Q37096469-03753308-C5DE-4F50-92DB-4DD81031C639 @default.
- Q37096469 P2860 Q37096469-05F1155A-3BC9-4F24-83CA-F58CF444DB96 @default.
- Q37096469 P2860 Q37096469-19F4FE77-88BF-4AE9-94AD-7C977CD0A95D @default.
- Q37096469 P2860 Q37096469-211268D9-6526-4D59-BF54-0F26C12FBA4D @default.
- Q37096469 P2860 Q37096469-2430E7E9-8D77-454B-9CAF-4F64512FF6E3 @default.
- Q37096469 P2860 Q37096469-2A43F86E-5224-44DA-8FCE-5094D137D97F @default.
- Q37096469 P2860 Q37096469-2EC2F819-9DBE-4FF7-A83F-E144FE007863 @default.
- Q37096469 P2860 Q37096469-30841F5D-5E1E-44DE-84D1-DDD2F9B3B89E @default.
- Q37096469 P2860 Q37096469-347F0E86-A790-461E-BB96-B4FD0B5537C0 @default.
- Q37096469 P2860 Q37096469-37EED417-9864-4688-B289-0453FDEFBD04 @default.
- Q37096469 P2860 Q37096469-3BFBB8C7-E24B-4BDA-8800-203EDC51E333 @default.
- Q37096469 P2860 Q37096469-4ABC40CC-3276-46E7-BB2E-90BFE00485F0 @default.
- Q37096469 P2860 Q37096469-4BBE75E9-2DFD-4C0D-AD5F-2DE356D38987 @default.
- Q37096469 P2860 Q37096469-502B2AE6-AB33-4B70-8364-3F69A2562FD2 @default.
- Q37096469 P2860 Q37096469-52995492-EF89-465B-AE77-B1347B4C12A6 @default.
- Q37096469 P2860 Q37096469-5EA40BF2-6344-48CB-9C7D-1F1863011D5A @default.
- Q37096469 P2860 Q37096469-66311E64-E844-4E2B-9F6F-3AED11C113CE @default.
- Q37096469 P2860 Q37096469-6CF95338-0592-4ECE-8F61-C6BF6223A2A9 @default.
- Q37096469 P2860 Q37096469-6F19C1D4-64DA-459A-BAE3-A76B9A5DB0B7 @default.
- Q37096469 P2860 Q37096469-77D6531F-0C78-470E-952D-BFF5B7858FE4 @default.
- Q37096469 P2860 Q37096469-7AE772F0-BE25-46CB-A919-B520EF04AD02 @default.
- Q37096469 P2860 Q37096469-7CE6F48E-AFDA-49C2-A1EB-A1A65D3BF916 @default.
- Q37096469 P2860 Q37096469-7F67EA60-D73A-4BBA-9F90-AB50B270C9D4 @default.
- Q37096469 P2860 Q37096469-836DCDA5-AAFA-4FAD-83E4-C330930CA094 @default.
- Q37096469 P2860 Q37096469-87380A36-4C1F-4B83-A8AD-536887074D9F @default.
- Q37096469 P2860 Q37096469-8A4E15C4-04A4-4CC8-B25B-BA2455B51DF2 @default.
- Q37096469 P2860 Q37096469-8E222EF7-8482-42E4-AE69-022DE5D00596 @default.
- Q37096469 P2860 Q37096469-94B16248-E795-4F5D-834B-25D8293B5AD2 @default.
- Q37096469 P2860 Q37096469-96E7386F-89B5-42C2-A96A-7497E2E84795 @default.
- Q37096469 P2860 Q37096469-9850B3AD-AA80-4988-A19B-0C333E55D146 @default.
- Q37096469 P2860 Q37096469-9F4B13DD-1156-4CF7-8EE3-AD6F17A5F1A9 @default.
- Q37096469 P2860 Q37096469-A12A1559-D9AE-4C01-B8CD-67CD231BC8A0 @default.
- Q37096469 P2860 Q37096469-ADE66B99-D9BF-44AD-B3EB-2F1D4E61581A @default.
- Q37096469 P2860 Q37096469-B373614A-B775-4DCA-A2B3-E4BDF6385735 @default.
- Q37096469 P2860 Q37096469-BB3439A2-CA02-4714-A8B3-2B0020160E17 @default.
- Q37096469 P2860 Q37096469-C5B7805E-C0C3-48BF-81C0-4FD611226C06 @default.
- Q37096469 P2860 Q37096469-C7637A0D-A912-4660-BD20-3CE0798E5B33 @default.
- Q37096469 P2860 Q37096469-D61BDBFC-85AB-4F17-8497-37778E230490 @default.
- Q37096469 P2860 Q37096469-E4844AAA-D92E-4A71-A667-F1F28C043FBB @default.
- Q37096469 P2860 Q37096469-F0E851B4-A9DB-4C36-9A05-6D0B8F8AA864 @default.
- Q37096469 P2860 Q37096469-F180BC92-C38D-4735-B7E5-0BA055E45DDA @default.
- Q37096469 P2860 Q37096469-F3297E7C-D229-4E8A-84B3-159A55CE2CC0 @default.
- Q37096469 P304 Q37096469-C71F2854-42B0-44ED-B420-ABE72865AB72 @default.
- Q37096469 P31 Q37096469-59297458-7F3D-40EF-B64E-DA47008F9E10 @default.
- Q37096469 P433 Q37096469-F0F66840-CE40-44D4-A1B8-0B802F07E8C3 @default.
- Q37096469 P478 Q37096469-816A9534-1D35-4467-8E47-B581AEF44913 @default.
- Q37096469 P577 Q37096469-733D3E1B-9663-4661-910C-96E19A675F54 @default.
- Q37096469 P698 Q37096469-2AF8E246-2C1A-45DE-8423-EF69F2C90BB6 @default.
- Q37096469 P921 Q37096469-72404F2E-D643-4050-9F6D-A642CC64EDD3 @default.
- Q37096469 P921 Q37096469-C2108F7D-009E-460B-BA60-98BCEC89040C @default.
- Q37096469 P932 Q37096469-578EB261-7F7F-4523-AF94-3B713B6A2ED6 @default.
- Q37096469 P698 23977448 @default.
- Q37096469 P1433 Q17511667 @default.
- Q37096469 P1476 "Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma" @default.
- Q37096469 P2093 "Christina A von Roemeling" @default.
- Q37096469 P2093 "Gregory T Kennedy" @default.
- Q37096469 P2093 "John A Copland" @default.
- Q37096469 P2093 "Laura A Marlow" @default.
- Q37096469 P2093 "Michael E Menefee" @default.
- Q37096469 P2093 "William P Kennedy" @default.
- Q37096469 P2860 Q24536108 @default.
- Q37096469 P2860 Q27860574 @default.
- Q37096469 P2860 Q27861062 @default.
- Q37096469 P2860 Q28131831 @default.
- Q37096469 P2860 Q28243712 @default.
- Q37096469 P2860 Q29547463 @default.
- Q37096469 P2860 Q29614242 @default.